SCHEMBL196846

SCHEMBL196846

CCCCCCNCCN

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.72
TSHR P16473 2/20 0.72
CA12 O43570 4/20 0.58
CA6 P23280 4/20 0.58
CA7 P43166 4/20 0.58
CA9 Q16790 4/20 0.58
CA14 Q9ULX7 4/20 0.58
CA5B Q9Y2D0 4/20 0.58
CA2 P00918 3/20 0.58
CA4 P22748 3/20 0.58
CA5A P35218 3/20 0.58
CA3 P07451 2/20 0.58
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
RECQL P46063 2/20 0.56
DNM1 Q05193 5/20 0.55
ALOX15 P16050 2/20 0.55
F13A1 P00488 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461707 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL11773029 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL474363 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL1109707 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL444890 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL448506 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL25409467 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL1548842 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL444731 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7
SCHEMBL11794778 1.00 ALDH1A1 (0.72) ALDH1A1TSHRCA12CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 719 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119604162-A Method for assisting in generating perovskite in-situ film formation through interface protonation reaction 温州锌芯钛晶科技有限公司 2025-03-11 CN claimed
US-20250019579-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-01-16 US claimed
EP-4437056-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS Bostik SA (FR) 2024-10-02 EP claimed
CN-118284673-A Compositions based on (meth) acrylate monomers 博斯蒂克股份公司 2024-07-02 CN claimed
EP-3033066-B1 POLYUREA OR POLYURETHANE CAPSULES INT FLAVORS & FRAGRANCES INC (US) 2023-07-12 EP claimed
WO-2023089252-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS BOSTIK SA (FR) 2023-05-25 WO claimed
CN-115838462-A Preparation method of aqueous polyurethane dispersion 万华化学集团股份有限公司 2023-03-24 CN claimed
CN-113429715-B Phosphorylated polyvinyl alcohol/perfluorinated sulfonic acid resin compound and ion exchange membrane 国家电投集团氢能科技发展有限公司 2022-09-02 CN claimed
CN-114805821-A Degradable antibacterial peptide based on cellulose and preparation method thereof 上海摩漾生物科技有限公司 2022-07-29 CN claimed
CN-113717339-B Curing agent for reducing volatile matters of adhesive 上海交通大学 2022-07-15 CN claimed
EP-1489126-A1 Polymers for the delivery of bioactive agents and methods of their preparation Agency for Science, Technology and Research (SG) 2004-12-22 EP claimed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP claimed
EP-1417190-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgen Inc. (US) 2004-05-12 EP claimed
EP-1416933-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgem, Inc. (US) 2004-05-12 EP claimed
US-20040006067-A1 Substituted piperidines and methods of use AMGEN INC. 2004-01-08 US claimed
US-20030220324-A1 Substituted piperazines and methods of use AMGEN INC. 2003-11-27 US claimed
WO-2003009850-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC. (US) 2003-02-06 WO claimed
WO-2003009847-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM, INC. (US) 2003-02-06 WO claimed
US-6165952-A Ashless rust inhibitor lubricant compositions KING INDUSTRIES, INC. (US) 2000-12-26 US claimed
CN-1239492-A Dithiocarbonate compositions KYOWA YUKA KK (JP) 1999-12-22 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220324-A1 Substituted piperazines and methods of use MC5R, MC4R, MC1R ALDH1A1 686/4885TSHR 271/4885CA12 3977/4885
US-20040006067-A1 Substituted piperidines and methods of use MC4R, MC5R, MC1R ALDH1A1 423/4885TSHR 303/4885CA12 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.